Fauci believes that Pfizer, Moderna and J&J vaccines will get full approval from FDA


On Tuesday, Dr. Anthony Fauci appeared on CNBC’s Squawk Box. The White House chief medical advisor said that he believed that the three major vaccines used in the nation — Pfizer-BioNtech, Moderna and Johnson & Johnson would get full approval from the U.S. Food and Drug Administration (FDA).


Dr. Fauci told CNBC that the data was “as good as it gets” and that he would be astounded if the vaccines did not get full approval. He also said that although they were under emergency use authorization (EUA), it was different from other EUA as those were granted with not as much positive data as that was available for the three approved COVID vaccines.


Pfizer and its German partner BioNTech had applied for full approval in May and Moderna applied for full approval on June 1. They had gotten EUA in December. Some believe that more Americans could take the shots after vaccines gain full approval. Companies could also implement vaccine mandates more easily, especially since the vaccination rate has been slowing down since spring.


Dr. Fauci and other officials had spoken to Pfizer on Monday, a day before his appearance on Squawk Box. He said that it was a courtesy meeting and emphasized that the discussion on booster shots had nothing to do with the efficacy of the vaccine.


He said that the unanswered question was about the duration of the protection and the level of protection. He said this was discussed and there was “nothing that came even close to any decision.”


Pfizer has been developing a booster dose to combat the delta variant of COVID-19 and is pursuing authorization. However, the Centers for Disease Control and Prevention (CDC) and the FDA have said that those who are fully vaccinated don’t need a booster shot, at present.


Author NIAID

Follow us on Google news for more updates and News


This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer